Mellissa Visit 1: Patient-centric Approaches to Dyslipidemia: Risk Recognition and Management of Low HDL-C
| Title: | Mellissa Visit 1: Patient-centric Approaches to Dyslipidemia: Risk Recognition and Management of Low HDL-C |
| Topic: | Cardiology |
| Relevant Terms: | Cardiometabolic Risk, Dyslipidemia |
| Primary Audience: | Cardiologists; Primary Care Physicians; Pharmacists; Nurses and Registered Dietitians |
| Launch Date: | 08-Mar-11 |
| Credits: | 0.5 AMA PRA Category 1 Credit™ 0.5 ACPE contact hour 0.5 ANCC contact hour 0.5 CDR continuing professional education unit |
| Expiration Date: | 08-Mar-12 |
Learning Objectives
Upon completion of the activity, participants should be able to:
- Discuss the strategy of HDL-C raising and aggressive LDL-C lowering as effective targets of treatment in light of recent clinical trial results.
- Highlight current concepts in how to diagnose and how and when, and in whom, to treat pathologic states of HDL in clinical patients.
- Discuss all of the current therapeutic approaches to therapeutically raising HDL levels, emphasizing those that will be available to clinicians first.
Faculty
James Underberg, MD, MS, FACPM, FACP, FNLA
Clinical Assistant Professor of Medicine
NYU Medical School
Director, Primary Care Lipid Management Clinic
Bellevue Hospital Lipid Clinic
New York, New York
Danielle Duffy, MD
Assistant Professor of Medicine
Division of Cardiology
Jefferson Medical College and Thomas Jefferson University
Philadelphia, PA
Jan L. McAlister, MSN, APRN, FPCNA, CLS, AACC
Adult Nurse Practitioner
Piedmont Heart Institute
Atlanta, GA
Clinical Assistant Professor of Medicine
NYU Medical School
Director, Primary Care Lipid Management Clinic
Bellevue Hospital Lipid Clinic
New York, New York
Danielle Duffy, MDAssistant Professor of Medicine
Division of Cardiology
Jefferson Medical College and Thomas Jefferson University
Philadelphia, PA
Jan L. McAlister, MSN, APRN, FPCNA, CLS, AACCAdult Nurse Practitioner
Piedmont Heart Institute
Atlanta, GA
Target Audience
This activity is designed to meet the educational needs of physicians, physician assistants, pharmacists, nurses and registered dietitians interested in lipid management.
Criteria for Success
This activity includes text and graphics and may include multimedia features. Click on all of the medical education activity links and review the content presented. This activity should take approximately 30 minutes to complete. There is no fee to participate in this activity.
To Obtain CME and CE Credits
- Read, complete, and submit answers to the examination and evaluation questions online.
- You must score 70% or higher to receive credit for this activity.
- Once you have successfully completed the examination and evaluation, a certificate will be automatically generated.
If you have questions about this CME/CE activity, please contact the NLA at cme@lipid.org.
Course Viewing Requirements
PC Internet Explorer (v6 or greater), or Firefox
MAC Safari
PC Internet Explorer (v6 or greater), or Firefox
MAC Safari
Commercial Support
This continuing education activity is supported by an educational grant from GlaxoSmithKline.
Accreditation
Accreditation
CME credit provided by the National Lipid Association.Physicians
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Lipid Association designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistant
AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
Dietitians
AKH Inc. is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 0.5 continuing professional education units (CPEUs) for completion of this program/material. Provider #AN008. The focus of this activity is rated Level 2.
Nurses
AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.
AKH Inc. designates this educational activity for 0.5 contact hours (0.05 CEU). Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
AKH Inc. designates this educational activity for 0.5 contact hours (0.05 CEU). Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
Pharmacists
AKH Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc. approves this knowledge-based activity for 0.5 contact hours (0.05 CEU). UAN 0077-9999-11-016-H04-P. Initial Release Date: 02/01/2011.
Faculty Disclosure Statement
It is the policy of NLA and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA and AKH prior to accreditation of the activity. NLA and AKH planners and reviewers have no relevant financial relationships to disclose.
Dr. Underberg has received research grant from Genzyme. He has also received honorarium from speakers bureau for Abbott Laboratories, AstraZeneca, Daiichi Sankyo, Inc., diaDexus, Inc., GlaxoSmithKline, LipoScience, Inc., Merck & Co., Inc., Merck/Schering Plough Pharmaceuticals, Novartis Pharmaceuticals.
Dr. Duffy has received research grants from Roche, Abbott Laboratories, and Forest Pharmaceuticals.
Ms. McAlister has acted as an educator for Alere and received honorarium for speakers bureau from Abbott Laboratories, GlaxoSmithKline, and Merck & Co., Inc.
Dr. Underberg has received research grant from Genzyme. He has also received honorarium from speakers bureau for Abbott Laboratories, AstraZeneca, Daiichi Sankyo, Inc., diaDexus, Inc., GlaxoSmithKline, LipoScience, Inc., Merck & Co., Inc., Merck/Schering Plough Pharmaceuticals, Novartis Pharmaceuticals.
Dr. Duffy has received research grants from Roche, Abbott Laboratories, and Forest Pharmaceuticals.
Ms. McAlister has acted as an educator for Alere and received honorarium for speakers bureau from Abbott Laboratories, GlaxoSmithKline, and Merck & Co., Inc.
Unlabeled and Investigational Usage
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. NLA, AKH Inc., the author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader's misunderstanding of the content.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities.
